An Act To Amend Maine'S Prescription Drug Labeling Law By Allowing The Removal Of The Name Of A Prescriber Of Mifepristone, Misoprostol And Their Generic Alternatives

LD 538 amends Maine's prescription drug labeling law to allow prescribers of mifepristone, misoprostol, and their generic alternatives to request that prescription labels display their healthcare facility's name instead of their personal name. This change would be optional and directly affect prescribers of these medications, as well as the labeling process for pharmacies handling these drugs. The bill does not require the change but provides an alternative for prescribers seeking to limit personal identification on labels. It applies only to the specified drugs and maintains existing requirements for other label information.